Skip to content
Amber and clear specimen vials arranged on a concrete laboratory bench
144 compounds · 21 protocols · 9 articles

A structured reference for peptide research.

Every compound documented with its mechanism, the human and preclinical evidence behind it, what remains unknown, and its regulatory context — plus reconstitution math that actually matches your vial.

144
Compounds
14
Categories
21
Protocols
379
Cited sources
720
Quiz questions

Evidence, graded

Every compound is tagged by the strongest tier of evidence available for it, so you can tell an FDA-approved molecule from a mouse study at a glance.

35
FDA-approved context
67
Human clinical
24
Early human
18
Preclinical only

Frequently referenced

Compounds most often discussed in the literature this database covers.

BPC-157

Healing & Recovery
Early human

BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.

250-500 mcg1-2 times daily

Tirzepatide (Mounjaro, Zepbound)

Weight Loss & Metabolism
FDA-approved context

Tirzepatide is a novel, first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Clinical research demonstrates unprecedented efficacy in improving glycemic control in type 2 diabetes and achieving substantial weight loss in individuals with obesity.

Prescription only - dosing determined by physicianPrescription only

Semaglutide (Ozempic, Wegovy)

Weight Loss & Metabolism
FDA-approved context

Semaglutide is a long-acting GLP-1 receptor agonist that mimics the natural incretin hormone GLP-1. Extensive clinical research demonstrates its profound efficacy in improving glycemic control in type 2 diabetes and inducing substantial, sustained weight loss in individuals with obesity.

Prescription medication - dosing not providedPrescription medication - dosing not provided

TB-500 (Thymosin Beta-4)

Healing & Recovery
Early human

TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.

2.0 - 2.5 mg per injection2 times per week (loading phase)

Ipamorelin

Growth Hormone
Human clinical

Ipamorelin is a highly selective growth hormone secretagogue and ghrelin receptor agonist. Research indicates it stimulates the pituitary gland to release endogenous growth hormone without significantly elevating cortisol or prolactin levels, making it a primary focus in studies on anti-aging, muscle preservation, and recovery.

200-300 mcg per dose1 to 2 times daily (often morning and/or before bed) via SubQ injection

KPV

Healing & Recovery
Early human

KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.

200-500 mcg/dayOnce or twice daily
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.